(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are IMAC Holdings, Hycroft Mining Holding Corporation, and Interpace Biosciences.

The three biggest losers today are Greenrose Acquisition Corp., TD Holdings, and Akerna Corp..

Winners today

1. IMAC Holdings (IMACW) – 284.62%

NASDAQ ended the session with IMAC Holdings jumping 284.62% to $0.01 on Wednesday while NASDAQ rose 0.54% to $14,019.31.

Yearly Top and Bottom Value

IMAC Holdings’s stock is valued at $0.01 at 17:32 EST, way below its 52-week low of $0.00.

More news about IMAC Holdings.

2. Hycroft Mining Holding Corporation (HYMCW) – 20%

Hycroft Mining Holding Corporation, together with its subsidiaries, operates as a gold and silver producer in the United States. The company holds interests in the Hycroft mine covering an area of approximately 70,671 acres located in the state of Nevada. As of December 31, 2020, its Hycroft mine had proven and probable mineral reserves of 11.9 million ounces of gold, and 478.5 million ounces of silver. Hycroft Mining Holding Corporation was formerly known as Mudrick Capital Acquisition Corporation. The company was incorporated in 2017 and is based in Denver, Colorado.

NASDAQ ended the session with Hycroft Mining Holding Corporation rising 20% to $0.03 on Wednesday, after five successive sessions in a row of losses. NASDAQ jumped 0.54% to $14,019.31, after three sequential sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Hycroft Mining Holding Corporation has a trailing twelve months EPS of $-1.543.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -91.04%.

Yearly Top and Bottom Value

Hycroft Mining Holding Corporation’s stock is valued at $0.03 at 17:32 EST, under its 52-week low of $0.03.

More news about Hycroft Mining Holding Corporation.

3. Interpace Biosciences (IDXG) – 17.65%

Interpace Biosciences, Inc. provides molecular diagnostic tests, bioinformatics, and pathology services for evaluating cancer risk in the United States. The company offers PancraGEN, a pancreatic cyst and pancreaticobiliary solid lesion genomic test that helps physicians better assess risk of pancreaticobiliary cancers using its PathFinderTG platform; and ThyGeNEXT, an oncogenic mutation panel to identify malignant thyroid nodules. It also provides ThyraMIR assesses thyroid nodules for risk of malignancy utilizing a proprietary microRNA gene-expression assay; and RespriDx, a genomic test that helps physicians to differentiate metastatic or recurrent lung cancer. The company also provides pharmacogenomics testing, genotyping, biorepository, and other customized services to the pharmaceutical and biotech industries. It primarily serves physicians, hospitals, and clinics. The company was formerly known as Interpace Diagnostics Group, Inc. and changed its name to Interpace Biosciences, Inc. in November 2019. Interpace Biosciences, Inc. was incorporated in 1986 and is headquartered in Parsippany, New Jersey.

NASDAQ ended the session with Interpace Biosciences rising 17.65% to $1.20 on Wednesday while NASDAQ jumped 0.54% to $14,019.31.

Earnings Per Share

As for profitability, Interpace Biosciences has a trailing twelve months EPS of $-0.38.

Yearly Top and Bottom Value

Interpace Biosciences’s stock is valued at $1.20 at 17:32 EST, way below its 52-week high of $3.54 and way higher than its 52-week low of $0.51.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Interpace Biosciences’s EBITDA is 0.4.

More news about Interpace Biosciences.

4. Goosehead Insurance (GSHD) – 15.16%

Goosehead Insurance, Inc. operates as a holding company for Goosehead Financial, LLC that provides personal lines insurance agency services in the United States. The company operates in two segments, Corporate Channel and Franchise Channel. It offers homeowner's, automotive, dwelling property, flood, wind, earthquake, excess liability or umbrella, motorcycle, recreational vehicle, general liability, property, and life insurance products and services. As of December 31, 2020, the company had 1,468 total franchises. Goosehead Insurance, Inc. was founded in 2003 and is headquartered in Westlake, Texas.

NASDAQ ended the session with Goosehead Insurance jumping 15.16% to $68.61 on Wednesday while NASDAQ rose 0.54% to $14,019.31.

Earnings Per Share

As for profitability, Goosehead Insurance has a trailing twelve months EPS of $0.32.

PE Ratio

Goosehead Insurance has a trailing twelve months price to earnings ratio of 214.41. Meaning, the purchaser of the share is investing $214.41 for every dollar of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth grew by 30.7%, now sitting on 240.75M for the twelve trailing months.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 25% and 172.7%, respectively.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Goosehead Insurance’s EBITDA is 6.42.

Sales Growth

Goosehead Insurance’s sales growth is 20.9% for the ongoing quarter and 21.9% for the next.

More news about Goosehead Insurance.

5. Harbor Custom Development (HCDI) – 12.7%

Harbor Custom Development, Inc. engages in the real estate development business in Western Washington's Puget Sound region. The company undertakes projects, such as residential lots, home communities, and single family and multi-family properties. It is involved in the land development cycle activities, including land acquisition, entitlements, construction of project infrastructure, home building, marketing, sales, and management of various residential projects. The company was formerly known as Harbor Custom Homes, Inc. and changed its name to Harbor Custom Development, Inc. in August 2019. Harbor Custom Development, Inc. was founded in 2014 and is headquartered in Gig Harbor, Washington.

NASDAQ ended the session with Harbor Custom Development rising 12.7% to $1.42 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.54% to $14,019.31, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Harbor Custom Development has a trailing twelve months EPS of $-33.68.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -28.26%.

Growth Estimates Quarters

The company’s growth estimates for the current quarter and the next is 106.6% and 108.3%, respectively.

More news about Harbor Custom Development.

6. Helius Medical Technologies (HSDT) – 10.77%

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-implantable investigational medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.

NASDAQ ended the session with Helius Medical Technologies jumping 10.77% to $7.20 on Wednesday while NASDAQ jumped 0.54% to $14,019.31.

Earnings Per Share

As for profitability, Helius Medical Technologies has a trailing twelve months EPS of $43.26.

PE Ratio

Helius Medical Technologies has a trailing twelve months price to earnings ratio of 0.17. Meaning, the purchaser of the share is investing $0.17 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -221.69%.

Moving Average

Helius Medical Technologies’s worth is way under its 50-day moving average of $8.99 and way below its 200-day moving average of $11.87.

More news about Helius Medical Technologies.

7. FuelCell Energy (FCEL) – 10.15%

FuelCell Energy, Inc., together with its subsidiaries, manufactures and sells stationary fuel cell energy platforms that decarbonize power and produce hydrogen. It offers SureSource 1500, a 1.4-megawatt (MW) platform; SureSource 3000, a 2.8 MW platform; SureSource 4000, a 3.7 MW platform; SureSource 250, a 250- kilowatt (kW) platform; SureSource 400, a 400-kW platform; and SureSource Hydrogen, a 2.3 MW platform that is designed to produce up to 1,200 kilograms of hydrogen per day for multi-megawatt utility, microgrid, and distributed hydrogen applications, as well as on-site heat and chilling applications. The company also provides SureSource platform in various configurations and applications, including on-site power, utility grid support, and microgrid, as well as distributed hydrogen; solutions for long duration hydrogen-based energy storage and electrolysis technology; and carbon capture, separation, and utilization systems. Its SureSource power plants generate electricity, heat, hydrogen, and water. In addition, the company provides turn-key solutions, including development, engineering, procurement, construction, interconnection, and operation services. It serves various markets, including utilities and independent power producers, industrial and process applications, education and health care, data centers and communication, wastewater treatment, government, microgrids, hydrogen transportation, food and beverage, and commercial and hospitality. The company primarily operates in the United States, South Korea, England, Germany, and Switzerland. FuelCell Energy, Inc. was founded in 1969 and is headquartered in Danbury, Connecticut.

NASDAQ ended the session with FuelCell Energy rising 10.15% to $1.47 on Wednesday while NASDAQ jumped 0.54% to $14,019.31.

Earnings Per Share

As for profitability, FuelCell Energy has a trailing twelve months EPS of $-0.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.18%.

Sales Growth

FuelCell Energy’s sales growth is negative 35.7% for the present quarter and negative 26.1% for the next.

Volume

Today’s last reported volume for FuelCell Energy is 7439560 which is 51.22% below its average volume of 15251800.

Revenue Growth

Year-on-year quarterly revenue growth grew by 134.1%, now sitting on 157.73M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

FuelCell Energy’s EBITDA is -18.5.

More news about FuelCell Energy.

8. HighPeak Energy (HPKEW) – 10.09%

NASDAQ ended the session with HighPeak Energy rising 10.09% to $6.33 on Wednesday, following the last session’s upward trend. NASDAQ jumped 0.54% to $14,019.31, after three sequential sessions in a row of gains, on what was a somewhat up trend trading session today.

Moving Average

HighPeak Energy’s worth is higher than its 50-day moving average of $6.01 and way under its 200-day moving average of $12.79.

More news about HighPeak Energy.

9. Greenlane Holdings (GNLN) – 9.86%

Greenlane Holdings, Inc. sells cannabis accessories, child-resistant packaging, and specialty vaporization products in the United States, Canada, Europe, Australia, and South America. The company provides vaporizers, liquid nicotine, storage solutions, pipes, apparel lines, and consumption accessories, as well as bubblers, rigs, and other smoking and vaporization related accessories and merchandise. It offers its products under the VIBES rolling papers, Pollen Gear, the Marley Natural accessory line, Aerospaced & Groove grinders, K. Haring Glass Collections, Eyce specialty silicone smoking products, and Higher Standards brands. The company also operates e-commerce websites, such as Vapor.com, Higherstandards.com, Aerospaced.com, Canada.vapor.com, Vaposhop.com, and others. It serves smoke shops, dispensaries, and specialty retail stores. The company was founded in 2005 and is headquartered in Boca Raton, Florida.

NASDAQ ended the session with Greenlane Holdings jumping 9.86% to $0.77 on Wednesday while NASDAQ jumped 0.54% to $14,019.31.

Earnings Per Share

As for profitability, Greenlane Holdings has a trailing twelve months EPS of $-104.96.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -88.1%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 50.8%, now sitting on 94.22M for the twelve trailing months.

Volume

Today’s last reported volume for Greenlane Holdings is 62838 which is 31.52% below its average volume of 91770.

Yearly Top and Bottom Value

Greenlane Holdings’s stock is valued at $0.77 at 17:32 EST, way below its 52-week high of $29.00 and way higher than its 52-week low of $0.70.

More news about Greenlane Holdings.

10. Healthcare Trust (HTIA) – 8.44%

Healthcare Trust, Inc. is a publicly registered real estate investment trust focused on acquiring a diversified portfolio of healthcare real estate, with an emphasis on seniors housing and medical office buildings, located in the United States.

NASDAQ ended the session with Healthcare Trust rising 8.44% to $17.21 on Wednesday, following the last session’s upward trend. NASDAQ rose 0.54% to $14,019.31, after three successive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, Healthcare Trust has a trailing twelve months EPS of $-1.07.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.04%.

Volume

Today’s last reported volume for Healthcare Trust is 18392 which is 109% above its average volume of 8800.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.7%, now sitting on 341.83M for the twelve trailing months.

More news about Healthcare Trust.

Losers Today

1. Greenrose Acquisition Corp. (GNRSW) – -99.98%

NASDAQ ended the session with Greenrose Acquisition Corp. sliding 99.98% to $0.00 on Wednesday, after five sequential sessions in a row of losses. NASDAQ jumped 0.54% to $14,019.31, after three successive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

More news about Greenrose Acquisition Corp..

2. TD Holdings (GLG) – -72.34%

TD Holdings, Inc. focuses on the new commodities trading business. The company was formerly known as Bat Group, Inc. and changed its name to TD Holdings, Inc. in March 2020. TD Holdings, Inc. is based in Beijing, the People's Republic of China.

NASDAQ ended the session with TD Holdings sliding 72.34% to $0.30 on Wednesday, following the last session’s downward trend. NASDAQ jumped 0.54% to $14,019.31, after three sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, TD Holdings has a trailing twelve months EPS of $-0.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -1.09%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

TD Holdings’s EBITDA is 1.63.

Volume

Today’s last reported volume for TD Holdings is 50598900 which is 7692.89% above its average volume of 649296.

Moving Average

TD Holdings’s value is way under its 50-day moving average of $0.56 and way under its 200-day moving average of $0.90.

Volatility

TD Holdings’s last week, last month’s, and last quarter’s current intraday variation average was 17.03%, 4.17%, and 5.60%.

TD Holdings’s highest amplitude of average volatility was 17.03% (last week), 8.27% (last month), and 5.60% (last quarter).

More news about TD Holdings.

3. Akerna Corp. (KERNW) – -24.44%

NASDAQ ended the session with Akerna Corp. dropping 24.44% to $0.03 on Wednesday, after five sequential sessions in a row of losses. NASDAQ rose 0.54% to $14,019.31, after three consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Yearly Top and Bottom Value

Akerna Corp.’s stock is valued at $0.03 at 17:32 EST, way below its 52-week high of $0.05 and above its 52-week low of $0.03.

More news about Akerna Corp..

4. Box (BOX) – -10.45%

Box, Inc. provides a cloud content management platform that enables organizations of various sizes to manage and share their content from anywhere on any device. The company's Software-as-a-Service platform enables users to collaborate on content internally and with external parties, automate content-driven business processes, develop custom applications, and implement data protection, security, and compliance features to comply with legal and regulatory requirements, internal policies, and industry standards and regulations. It also offers web, mobile, and desktop applications for cloud content management on a platform for developing custom applications, as well as industry-specific capabilities. As of January 31, 2023, the company had approximately 100,000 paying organizations, and its solution was offered in 25 languages. It serves financial services, health care, government, and legal services industries in the United States and internationally. The company was formerly known as Box.net, Inc. and changed its name to Box, Inc. in November 2011. Box, Inc. was incorporated in 2005 and is headquartered in San Francisco Bay Area, California.

NYSE ended the session with Box falling 10.45% to $27.58 on Wednesday, after five sequential sessions in a row of gains. NYSE rose 0.2% to $16,074.22, after three successive sessions in a row of gains, on what was a somewhat up trend trading session today.

Earnings Per Share

As for profitability, Box has a trailing twelve months EPS of $0.14.

PE Ratio

Box has a trailing twelve months price to earnings ratio of 197. Meaning, the purchaser of the share is investing $197 for every dollar of annual earnings.

Previous days news about Box

• Box (box) surpasses Q2 earnings and revenue estimates. According to Zacks on Tuesday, 29 August, "While Box has underperformed the market so far this year, the question that comes to investors’ minds is: what’s next for the stock?"

More news about Box.

5. Hewlett (HPQ) – -9.18%

HP Inc. provides personal computing and other access devices, imaging and printing products, and related technologies, solutions, and services in the United States and internationally. The company operates through three segments: Personal Systems, Printing, and Corporate Investments. The Personal Systems segment offers commercial and consumer desktops and notebooks, workstations, commercial mobility devices, thin clients, retail point-of-sale systems, displays and peripherals, software, support, and services, as well as video conferencing solutions, cameras, headsets, voice, and related software products. The Printing segment provides consumer and commercial printer hardware, supplies, solutions, and services, as well as focuses on graphics and 3D imaging solutions in the commercial and industrial markets. The Corporate Investments segment is involved in the HP Labs and business incubation, and investment projects. It serves individual consumers, small- and medium-sized businesses, and large enterprises, including customers in the government, health, and education sectors. The company was formerly known as Hewlett-Packard Company and changed its name to HP Inc. in October 2015. HP Inc. was founded in 1939 and is headquartered in Palo Alto, California.

NYSE ended the session with Hewlett dropping 9.18% to $28.49 on Wednesday, after five consecutive sessions in a row of gains. NYSE jumped 0.2% to $16,074.22, after three consecutive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Hewlett has a trailing twelve months EPS of $2.67.

PE Ratio

Hewlett has a trailing twelve months price to earnings ratio of 10.67. Meaning, the purchaser of the share is investing $10.67 for every dollar of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Hewlett’s stock is considered to be oversold (<=20).

More news about Hewlett.

6. Ideanomics (IDEX) – -5.75%

Ideanomics, Inc. focuses on driving the adoption of commercial electric vehicles, associated energy consumption, and developing financial services and fintech products. Its Ideanomics Mobility division facilitates the adoption of electric vehicles by commercial fleet operators. This division also offers solutions for the procurement, financing, charging, and energy management needs for fleet operators of commercial electric vehicles. The company's Ideanomics Capital division provides fintech services, which focuses on the enhancement of efficiency, transparency, and profitability for the financial services industry. Ideanomics, Inc. was incorporated in 2004 and is headquartered in New York, New York.

NASDAQ ended the session with Ideanomics dropping 5.75% to $3.28 on Wednesday while NASDAQ rose 0.54% to $14,019.31.

Earnings Per Share

As for profitability, Ideanomics has a trailing twelve months EPS of $-54.54.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -158.82%.

Moving Average

Ideanomics’s worth is way under its 50-day moving average of $9.40 and way below its 200-day moving average of $14.82.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Ideanomics’s EBITDA is 0.77.

Yearly Top and Bottom Value

Ideanomics’s stock is valued at $3.28 at 17:32 EST, way below its 52-week high of $83.75 and way higher than its 52-week low of $2.50.

Volume

Today’s last reported volume for Ideanomics is 657948 which is 15.35% above its average volume of 570350.

More news about Ideanomics.

7. Kintara Therapeutics (KTRA) – -5.39%

Kintara Therapeutics, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. It is developing two late-stage, Phase III-ready therapeutics, including VAL-083, a DNA-targeting agent for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma; and REM-001, a photodynamic therapy for the treatment of cutaneous metastatic breast cancer. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China. The company was formerly known as DelMar Pharmaceuticals, Inc. and changed its name to Kintara Therapeutics, Inc. in August 2020. Kintara Therapeutics, Inc. was founded in 2009 and is headquartered in San Diego, California.

NASDAQ ended the session with Kintara Therapeutics dropping 5.39% to $4.66 on Wednesday, after three sequential sessions in a row of gains. NASDAQ rose 0.54% to $14,019.31, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, Kintara Therapeutics has a trailing twelve months EPS of $-14.08.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -254.48%.

More news about Kintara Therapeutics.

8. InflaRx N.V. (IFRX) – -4.59%

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in the Germany and United States. Its C5a is an inflammatory mediator that is involved in the enhancement of a variety of autoimmune and other inflammatory diseases. The company's lead product candidate is IFX-1, an intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase IIb clinical trial for the treatment of hidradenitis suppurativa, a rare and chronic debilitating systemic inflammatory skin disease; to treat ANCA-associated vasculitis, a rare and life-threatening autoimmune disease; and for the treatment of pyoderma gangrenosum, a chronic inflammatory skin disorder, as well as developing IFX-1 for the treatment of oncological diseases. It also develops IFX-2 that is in pre-clinical development stage for the treatment of chronic inflammation and autoimmune diseases. InflaRx N.V. has co-development agreement with Beijing Defengrei Biotechnology Co. Ltd. The company was formerly known as Fireman B.V. and changed its name to InflaRx N.V. in 2017. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany.

NASDAQ ended the session with InflaRx N.V. falling 4.59% to $3.74 on Wednesday while NASDAQ jumped 0.54% to $14,019.31.

Earnings Per Share

As for profitability, InflaRx N.V. has a trailing twelve months EPS of $-0.86.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.07%.

Moving Average

InflaRx N.V.’s worth is below its 50-day moving average of $4.03 and way higher than its 200-day moving average of $3.31.

Yearly Top and Bottom Value

InflaRx N.V.’s stock is valued at $3.74 at 17:32 EST, way below its 52-week high of $7.25 and way above its 52-week low of $1.57.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is a negative 36.8% and positive 10.5% for the next.

Volume

Today’s last reported volume for InflaRx N.V. is 93475 which is 57.46% below its average volume of 219779.

More news about InflaRx N.V..

9. GoHealth (GOCO) – -4.06%

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Internal; and Individual and Family Plans and Other—External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carrier and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois.

NASDAQ ended the session with GoHealth dropping 4.06% to $16.32 on Wednesday while NASDAQ rose 0.54% to $14,019.31.

Earnings Per Share

As for profitability, GoHealth has a trailing twelve months EPS of $-14.49.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -50.17%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 10%, now sitting on 528.36M for the twelve trailing months.

Sales Growth

GoHealth’s sales growth is 0.1% for the current quarter and 9.5% for the next.

Moving Average

GoHealth’s worth is way below its 50-day moving average of $18.66 and higher than its 200-day moving average of $15.40.

More news about GoHealth.

10. Nio (NIO) – -3.37%

NIO Inc. designs, develops, manufactures, and sells smart electric vehicles in China. It offers five and six-seater electric SUVs, as well as smart electric sedans. The company also offers power solutions, including Power Home, a home charging solution; Power Swap, a battery swapping service; Power Charger and Destination Charger; Power Mobile, a mobile charging service through charging vans; Power Map, an application that provides access to a network of public chargers and their real-time information; and One Click for Power valet service. In addition, it provides repair, maintenance, and bodywork services through its NIO service centers and authorized third-party service centers; statutory and third-party liability insurance, and vehicle damage insurance through third-party insurers; repair and routine maintenance; courtesy vehicle services; roadside assistance; data packages; and auto financing and financial leasing services. Further, the company involved in the provision of energy and service packages to its users; design and technology development activities; manufacture of e-powertrains, battery packs, and components; and sales and after sales management activities. Additionally, it offers NIO Certified, a used vehicle inspection, evaluation, acquisition, and sales service. The company was formerly known as NextEV Inc. and changed its name to NIO Inc. in July 2017. NIO Inc. was incorporated in 2014 and is headquartered in Shanghai, China.

NYSE ended the session with Nio sliding 3.37% to $10.52 on Wednesday while NYSE jumped 0.2% to $16,074.22.

: nio stock falls again, in wake of downbeat results but upbeat outlookShares of Nio Inc. slid 2.6% in premarket trading Wednesday, to extend their selloff in the wake of the China-based electric vehicle maker’s has gained 5% and the S&P 500 has tacked on 7%.

Earnings Per Share

As for profitability, Nio has a trailing twelve months EPS of $-1.49.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -58.01%.

Yearly Top and Bottom Value

Nio’s stock is valued at $10.52 at 17:32 EST, way below its 52-week high of $22.74 and way above its 52-week low of $7.00.

Previous days news about Nio

• Chinese EV maker nio reports results below analyst estimates. According to MarketWatch on Tuesday, 29 August, "Shares of Nio Inc. slipped Tuesday, after the China-based electric-vehicle maker reported second-quarter results that missed expectations but provided an upbeat revenue outlook for the current quarter."
• Nio stock earnings: NIO price slides amid Q2 results again missing consensus. According to FXStreet on Tuesday, 29 August, "During the second quarter, Abu Dhabi purchased an approximately $739 million stake directly from Nio and about $350 million in common stock from a subsidiary of Tencent (TCEHY).", "A break of $10.15, however, will produce more selling that send the Nio stock price down to earlier resistance-turned-support at $9.50."

More news about Nio.

Stay up to date with our winners and losers daily report